LINC 2019 presentations


LINC 2019, the Leipzig Interventional Course,  featured state-of-the-art lectures and numerous live cases have been performed from leading interventional centers.

LINC 2019 took place from Tuesday, January 22 through Friday, January 25, 2019.

LINC 2019 programme

Find all topics and speakers listed below.

Room 1 - Main Arena 1

21 events
  • Tuesday, January 22nd: - , Room 1 - Main Arena 1

    Symposium: Keep on walking: Steps towards successfull PAD treatment

    Moderator:
    Dierk Scheinert
    Panel:
    Thomas Zeller, Jonathan Sobocinski, Koen Deloose, Jörg Teßarek, Shannon Thomas
    1. -

      Step by step SFA/pop treatment algorithm

        Thomas Zeller
    2. -

      Step by step selection algorithm and clinical decision making through OCT technology

        Jonathan Sobocinski
    3. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    4. -

      Supera CFA VMI 1-year follow-up results

        Koen Deloose
    5. -

      Supera in AVF management and 1-year outcomes

        Shannon Thomas
    6. -

      Supera in popliteal aneurysm, proof of concept, and clinical outcomes

        Jörg Teßarek
    7. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
  • Tuesday, January 22nd: - , Room 1 - Main Arena 1

    Symposium: See clearly, treat optimally: image guided therapy on the rise

    Moderator:
    Dierk Scheinert, Frans Moll
    Panel:
    Constantino Peña, Jim A. Reekers, Fabrizio Fanelli, Maria Louisa Izamis
    1. -

      Introduction and learning objectives

        Dierk Scheinert
    2. -

      Next generation pan-vascular suite: optimizing patient management and outcomes

        Constantino Peña
    3. -

      Perfusion angiography for optimizing planning and treatment of diabetic foot

        Jim A. Reekers
    4. -

      BTK recorded case presentation

        Marco Manzi
    5. -

      Role of IVUS within a “treat optimally” algorithm of care

        Fabrizio Fanelli
    6. -

      Innovations at the forefront: a glance at the future of image guided therapy

        Maria Louisa Izamis
    7. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    8. -

      Q&A and conclusion

  • Tuesday, January 22nd: - , Room 1 - Main Arena 1

    Long-term safety of drug-eluting technologies in the leg – recent findings, controversies, and future outlook

    Moderator:
    Dierk Scheinert, John Laird
    Panel:
    Konstantinos Katsanos, Peter Schneider, Michael Dake, Thomas Zeller, William Gray, Sean Lyden
    1. -

      Risk of death following application of Paclitaxel-coated balloons and stents in the femoropopliteal artery – findings from a metaanalysis of RCTs

        Konstantinos Katsanos
    2. -

      A look into the methods: merits and limits of meta-analysis

        Timothy Hanson
    3. -

      Toxicological aspects and safety profile of Paclitaxel

        Juan Fernando Granada Solis
    4. -

      Event adjudication in clinical trials: how does it work?

        Marc van Sambeek
    5. PATIENT LEVEL DATA FROM MAJOR CLINICAL TRIAL PROGRAMMES WITH DRUG-ELUTING DEVICES

    6. -

      DCBs over the long-term: Are they safe for our PAD patients? Insights from the In.Pact DCB programme

        Peter Schneider
    7. -

      Long-term safety data of the Lutonix DCB formulation

        Dierk Scheinert
    8. -

      Long-term safety data from the Stellarex DCB programme

        Sean Lyden
    9. -

      Long-term safety information on Paclitaxel eluting stents – insights from the Zilver PTX programme

        Michael Dake
    10. -

      Patient safety in the Eluvia-DES and Ranger DCB programme

        William Gray
    11. -

      How to proceed to generate more evidence on patient safety with drug-eluting devices

        Peter Schneider
    12. -

      Podium discussion

  • Tuesday, January 22nd: - , Room 1 - Main Arena 1

    “To stent or not to stent?” – Latest data on stentless and stent-based treatment approaches for femoropopliteal lesions

    Moderator:
    Dierk Scheinert, William Gray
    Panel:
    Osamu Iida, Gunnar Tepe, Hiroyoshi Yokoi
    1. FOCUS ON NEW DATA ON DRUG-COATED BALLOONS

    2. -

      First time data release: Randomized trial of DCB vs. PTA: Final 3-year clinical outcomes from IN.PACT Japan

        Osamu Iida
    3. -

      First time data release: Insights from the IN.PACT global study 3-year data: Does lesion complexity affect results?

        Jos van den Berg
    4. -

      First time data release: Global diabetic analyses of all Lutonix DCB SFA combined trials

        Koen Deloose
    5. -

      First time data release: COMPARE-Pilot RCT: 2-year results of a randomized comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions

        Dierk Scheinert
    6. -

      First time data release: IN.PACT Global study 3-year outcomes for stented vs. non-stented lesions

        Thomas Zeller
    7. -

      First time data release: Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries: 24-month results of the BIOLUX P-III full cohort

        Gunnar Tepe
    8. -

      DCB in severe Calcium: Core-laboratory analysis and perspectives from the ILLUMENATE trial series

        Sean Lyden
    9. -

      Stellarex in real world: Interim look from the SAVER registry

        Frank Vermassen
    10. FOCUS ON NEW DATA ON DRUG-ELUTING STENTS AND DCB/IMPLANT COMBINATIONS

    11. -

      First time data release: Final 12-month results of the Zilverpass-RCT of Zilver PTX vs. bypass

        Marc Bosiers
    12. -

      TOBA II Trial (Lutonix or POBA + Tack) – 1-year results

        William Gray
    13. -

      First time data release: Diabetic patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents

        Stefan Müller-Hülsbeck
    14. -

      First time data release: Japanese patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents

        Osamu Iida
    15. -

      First time data release: Zilver PTX Japan 5-year results for paclitaxel-eluting stent treatment of femoropopliteal artery disease

        Hiroyoshi Yokoi
    16. -

      The Illumina FIH study with a next generation DES – 12-month results

        Dierk Scheinert
    17. -

      Discussion and conclusion

  • Tuesday, January 22nd: - , Room 1 - Main Arena 1

    Symposium: Strategies and innovative solutions for success in complex peripheral arterial disease

    Moderator:
    Dierk Scheinert
    Panel:
    John Laird, Theodosios Bisdas, Konstantinos Stavroulakis, Jos van den Berg
    1. -

      Endovascular lessons learned in the last decade: what are the remaining challenges?

        Theodosios Bisdas
    2. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    3. -

      Long lesions: primary stenting or DCB first?

        John Laird
    4. -

      Calcium: The Achilles heel of endovascular? Scaffold or remove before drug delivery?

        Konstantinos Stavroulakis
    5. -

      Live case transmission from New York

        Mount Sinai Hospital New York - Live case center
    6. -

      Dissections: prevent, minimize, or repair

        Jos van den Berg
    7. -

      Discussion and conclusion

  • Tuesday, January 22nd: - , Room 1 - Main Arena 1

    Symposium: Virtues of VIRTUS: Exploring implications for clinical practice

    Moderator:
    Stephen Black
    Panel:
    Mahmood Razavi, Michael Lichtenberg, Luis Izquierdo, Lowell Kabnick
    1. -

      Welcome and introduction

        Stephen Black
    2. -

      VIRTUS: Trial design and primary endpoint results

        Mahmood Razavi
    3. -

      VICI VENOUS STENT: Design attributes & patient outcome

        Lowell Kabnick
    4. -

      Panel discussion and questions

    5. -

      Complexities of chronic venous disease

        Michael Lichtenberg
    6. -

      Imaging, its central role in planning and guiding intervention

        Luis Izquierdo
    7. -

      Live case transmission from Galway

        Galway University Hospital - Live case center
    8. -

      Panel discussion and questions

  • Tuesday, January 22nd: - , Room 1 - Main Arena 1

    Advanced solutions for complex femoral lesions and critical limb ischemia

    Moderator:
    John Laird, Marc Bosiers
    Panel:
    Jos van den Berg, Yann Gouëffic, Lawrence Garcia, Stefan Müller-Hülsbeck, Brian DeRubertis, Torsten Fuß
    1. -

      True minimally invasive access strategies for complex peripheral interventions

        Jos van den Berg
    2. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    3. -

      First time data release: Can Legflow® improve treatment of long femoropopliteal lesions: the REFLOW outcomes

        Marc Bosiers
    4. -

      First time data release: Total IN.PACT™ 1-year results: Complex lesion outcomes from the IN.PACT study series

        Peter Schneider
    5. -

      IN.PACT Admiral DCB: a look at long lesion outcomes across trials

        Antonio Micari, Via satellite from Bergamo
    6. -

      From research to practice: how does atherectomy fit in my treatment algorithm

        Grigorios Korosoglou
    7. -

      Live case transmission from New York

        Mount Sinai Hospital New York - Live case center
    8. -

      REALITY: Initial experience

        Ravish Sachar
    9. -

      Phoenix atherectomy: technique and real-world evidence

        Miguel Montero-Baker
  • Wednesday, January 23rd: - , Room 1 - Main Arena 1

    Optimizing the treatment of BTK vessels in critical limb ischemia: Focus on new trials, drug-eluting technologies, and new implants

    Moderator:
    Dierk Scheinert, Jihad Mustapha
    Panel:
    Marc Bosiers, Peter Schneider, Ehrin Armstrong, Frank Vermassen, Ramon Varcoe, Francesco Liistro
    1. -

      Update on the BEST-trial: How will it change our practice

        Matthew Menard
    2. -

      Endovascular treatment vs. bypass surgery in CLI patients with chronic kidney disease

        Theodosios Bisdas
    3. -

      First time data release: In depth look at Lutonix safety events with difficult lesion 6-month BTK IDE Update

        Jihad Mustapha
    4. -

      First time data release: Interim 24-month results from the global LUTONIX® 014 DCB real world BTK registry

        Michael Lichtenberg
    5. -

      First time data release: Paclitaxel-coated balloon in below-the-knee lesions: 6-month results from the Ranger BTK single center study

        Costantino del Giudice
    6. -

      First time data release: Initial experience with the temporary spur stent system: DEEPER trial first-in-man results

        Jihad Mustapha
    7. -

      New DCB era for BTK: 6-month results from the China AcoArt II study

        Wei Guo
    8. -

      Drug-coated balloons in BTK: Where do we stand and what are the open questions?

        Marc Bosiers
    9. -

      Alternative methods of drug delivery in BTK vessels – Initial insights from the TANGO trial

        Ehrin Armstrong
    10. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    11. -

      How to reduce dissections in BTK: Techniques & devices

        Jos van den Berg
    12. -

      Size matters: experimental study on the effect of oversizing during tibial PTA

        Olaf Bakker
    13. -

      Initial experience with a new 3F compatible microstent for BTK revascularisation

        Robert Beasley
    14. -

      The demise of the absorb BVS. Why it failed, what we learned from the coronary experience, and is there is a future for bioresorbable scaffolds below-the-knee?

        Ramon Varcoe
    15. -

      Discussion and conclusion

  • Wednesday, January 23rd: - , Room 1 - Main Arena 1

    Symposium: Data supported solutions for peripheral arterial disease intervention

    Moderator:
    Dierk Scheinert, Yann Gouëffic
    Panel:
    Konstantinos Katsanos, Costantino del Giudice, Stefan Müller-Hülsbeck
    1. -

      Introduction and learning objectives

        Yann Gouëffic
    2. -

      Benchmarking Ranger drug-coated balloon data in SFA treatment

        Dierk Scheinert
    3. -

      Downstaging complexity for a DCB strategy in claudicants

        Konstantinos Katsanos
    4. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    5. -

      Gauging performance in below-the-knee intervention

        Costantino del Giudice
    6. -

      Raising the bar with Eluvia drug-eluting stent data

        Stefan Müller-Hülsbeck
    7. -

      Close and take aways

  • Wednesday, January 23rd: - , Room 1 - Main Arena 1

    Optimizing the treatment of BTK vessels in critical limb ischemia: Focus on imaging, revascularisation strategies, atherectomy, and assessment of results

    Moderator:
    Peter Schneider, Roberto Ferraresi
    Panel:
    Jim A. Reekers, Miguel Montero-Baker, George Adams, Yoshimitsu Soga, Marco Manzi
    1. -

      Critical limb ischemia: Have we made improvement in classifying these patients in a better way?

        Marianne Brodmann
    2. -

      Tips and tricks to optimize preinterventional imaging with CO2 angiography and no-contrast MR angiography

        Jos van den Berg
    3. -

      Wound and surgery-guided revascularisation & flow-guided surgery: the multidisciplinary approach to limb salvage

        Roberto Ferraresi
    4. -

      When is below-the-ankle angioplasty indicated and how to introduce it into your practice?

        Peter Schneider
    5. -

      Live case transmission from Münster

        St. Franziskus Hospital Münster - Live case center
    6. -

      How to optimize acute success and drug effect of DCB in BTK vessels?

        Michael Lichtenberg
    7. -

      The role of orbital atherectomy for optimization of BTK revascularisation results

        Peter Schneider
    8. -

      Versatility of directional atherectomy: Clinical use below-the-knee

        Ravish Sachar
    9. -

      Assessing foot perfusion after BTK revascularisation: Role of perfusion angiography and upcoming techniques

        Miguel Montero-Baker
    10. -

      Perfusion imaging of the foot in CLI-patients: prognostic value of pharmacological interventions

        Peter Huppert
    11. -

      Is non-functional microcirculation the same as flow-independent ischemia?

        Jim A. Reekers
    12. -

      Discussion and conclusion

  • Wednesday, January 23rd: - , Room 1 - Main Arena 1

    Focus session: Pioneering approaches for “no-option” patients

    live from Leipzig:
    Steven Kum, Andrej Schmidt
    Moderator:
    Jihad Mustapha, Marianne Brodmann
    Panel:
    Roberto Ferraresi, Peter Schneider, Ehrin Armstrong
    1. Flash presentation: No option CLI – A rising epidemic and an overview of solutions

        Marco Manzi
    2. Flash presentation: Surgical and hybrid venous arteriolisation – How to perform it and what are the limitations

        Roberto Ferraresi
    3. Flash presentation: Update on the PROMISE I early feasibility study in the US and global experience

        Jihad Mustapha
    4. Flash presentation: Rationale and design of a pivotal study for an autologous blood filter device for treatment of critical limb ischemia

        Bijan Modarai
  • Wednesday, January 23rd: - , Room 1 - Main Arena 1

    Symposium: Lutonix® DCB – The next clinically proven frontier for SFA, BTK, and AV treatment algorithms

    Moderator:
    Dierk Scheinert
    Panel:
    Koen Deloose, Patrick Geraghty, Aloke Finn, Scott Trerotola, Yoshimitsu Soga
    1. -

      Global CTO analyses of all Lutonix DCB SFA combined trials

        Koen Deloose
    2. -

      A closer look at the benefit of LTX DCB in diabetic patient in Japan

        Yoshimitsu Soga
    3. -

      Comparison of overall LTX BTK IDE 6-month outcomes to global registry

        Patrick Geraghty
    4. -

      Comparative studies of downstream events with drug coated balloon

        Aloke Finn
    5. -

      Sub-group analysis from LTX AV randomised trial

        Scott Trerotola
    6. -

      Review and comparisons of DCB global registries

        Koen Deloose
    7. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    8. -

      Discussion and conclusion

  • Wednesday, January 23rd: - , Room 1 - Main Arena 1

    VIVA@LINC: Carotid revascularisation redux: A whole new horizon?

    Moderator:
    Peter Schneider, Chris Metzger
    Panel:
    Sean Lyden, William Gray, John Laird, Ehrin Armstrong
    1. -

      Announcement of the winners of the Vascular Carreer Award 2018

        Peter Schneider
    2. -

      Live case transmission from Columbus

        OhioHealth Research Institute - Live case center
    3. -

      Transcervical carotid stenting (TCAR) is a game changer and a re-boot for CAS

        Peter Schneider
    4. -

      Cognitive decline with untreated carotid lesions: fact or fiction?

        John Laird
    5. -

      Timing of carotid bifurcation repair after symptoms: how does it affect stroke risk?

        Chris Metzger
    6. -

      Live case transmission from Columbus

        OhioHealth Research Institute - Live case center
    7. -

      Will mesh covered stents help reduce the risk of stroke?

        William Gray
  • Wednesday, January 23rd: - , Room 1 - Main Arena 1

    The remaining challenges: Long CTO lesions and in-stent restenosis

    Moderator:
    Sean Lyden, Ramon Varcoe
    Panel:
    Michael Dake, Jorge Fernández Noya, Sabine Steiner, Dai-Do Do
    1. -

      First time data release: Intravascular ultrasound supported endovascular therapy in superficial femoral artery disease: 12-month results from the IVORY-study

        Osamu Iida
    2. -

      Insights from Global Zilver PTX experience: What are the predictors for clinical failure and TLR?

        Michael Dake
    3. -

      CTO vs. non-CTO lesions: What are the lessons learned from the Real-PTX trial and the concept of the BEST-SFA trial?

        Sabine Steiner
    4. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    5. -

      Complex case review: Versatility of the GORE® VIABAHN® endoprosthesis in the treatment of challenging peripheral disease

        Jorge Fernández Noya
    6. -

      Combination therapy tackling ISR: laser + DCB 2-year results

        Ehrin Armstrong
    7. -

      Advancing laser therapy: different settings for different lesions

        George Adams
    8. -

      Live case transmission from Columbus

        OhioHealth Research Institute - Live case center
    9. -

      Discussion and conclusion

  • Thursday, January 24th: - , Room 1 - Main Arena 1

    The last frontiers: Extreme BTK interventions

    Moderator:
    Chris Metzger, Roberto Ferraresi
    Panel:
    Robert Beasley, Jihad Mustapha, Wei Guo, Francesco Liistro, Marianne Brodmann, Luis Mariano Palena
    1. -

      Live case transmission from Abano Terme

        Policlinico Abano Terme - Live case center
    2. -

      SAD transmission & BAD distribution: who is today a no-option CLI patient?

        Roberto Ferraresi
    3. -

      Peroneal access technique: How I do it and when do I consider it?

        Miguel Montero-Baker
    4. -

      Calcified below-the-knee lesions – overview of treatment options

        Erwin Blessing
    5. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    6. -

      An evaluation of drug eluting technologies for BTK treatment

        Marianne Brodmann
    7. -

      DCB in BTK: Why and where should we use it

        Francesco Liistro
    8. -

      Prestige pilot: Phoenix atherectomy and Stellarex DCB in infrapopliteal interventions

        Michael Lichtenberg
  • Thursday, January 24th: - , Room 1 - Main Arena 1

    Symposium: Mechanical atherectomy and thrombectomy of arterial and venous occlusions

    Moderator:
    Dierk Scheinert, Romaric Loffroy
    Panel:
    Bruno Freitas, Christian Wissgott, Michael Lichtenberg
    1. -

      Atherectomy and thrombectomy of femoropopliteal occlusions with Rotarex ®S: The Leipzig experience

        Bruno Freitas
    2. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    3. -

      Retrospective analysis of initial results of an atherothrombectomy device in patients with acute, subacute, and chronic lower limb artery occlusion

        Christian Wissgott
    4. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    5. -

      Safety, procedural success, and outcomes of the Aspirex® S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis: data from the Arnsberg Aspirex registry

        Michael Lichtenberg
  • Thursday, January 24th: - , Room 1 - Main Arena 1

    Endo-vascular transcendence in end stage renal disease

    Moderator:
    Dierk Scheinert
    Panel:
    Robert Jones, Bart Dolmatch, Panagiotis Kitrou, Roberto Ferraresi, Tobias Steinke, Robert Shahverdyan
    1. -

      Endovascular therapy first in ESRD

        Bart Dolmatch
    2. -

      CLI in ERSD. Upper & lower limb ischemia

        Roberto Ferraresi
    3. -

      WavelinQ endo-vascular access creation

        Robert Jones
    4. -

      Different approaches in WavelinQ endo-vascular access

        Robert Shahverdyan
    5. -

      Recorded case presentation

        Robert Shahverdyan
    6. -

      Treating the dysfunctional AV. From algorithm to Tips & Tricks

        Panagiotis Kitrou
    7. -

      Proof is in the evidence

        Dierk Scheinert
    8. -

      Live case transmission from Münster

        St. Franziskus Hospital Münster - Live case center
    9. -

      Discussion and conclusion

  • Thursday, January 24th: - , Room 1 - Main Arena 1

    Lunch

  • Thursday, January 24th: - , Room 1 - Main Arena 1

    The last frontiers: Endovascular therapy of the common femoral artery and the popliteal segment

    Moderator:
    Lawrence Garcia, Yann Gouëffic
    Panel:
    Sebastian Debus, Frank Criado, Erwin Blessing, Matthew Menard, Wei Liang
    1. -

      Long term (10 years) outcomes using VIABAHN for the treatment of PAA

        Ignace Tielliu
    2. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    3. LINC STATUS UPDATE: MANAGEMENT OF COMMON FEMORAL DISEASE

    4. -

      Lesions of the CFA: Increasing evidence for endovascular rather than open repair!

        Martin Malina
    5. -

      I disagree: Surgical reconstruction is still the gold standard for CFA reconstruction

        Matthew Menard
    6. -

      Panel discussion and audience vote

    7. -

      Live case transmission from Bad Krozingen

        Heartcenter Bad Krozingen - Live case center
    8. -

      Intravascular Lithotripsy as a treatment option for calcified stenosis of the common femoral artery: initial experiences

        Erwin Blessing
    9. -

      Directional atherectomy and anti-restenotic therapy for CFA disease

        Thomas Zeller, Via satellite from Bad Krozingen
    10. -

      2-year outcomes of directional atherectomy and anti-restenotic therapy in CFA disease

        Angelo Cioppa
    11. -

      A valuable alternative for CFA endarterectomy? The use of the Supera vascular mimetic implant for the treatment of atherosclerotic disease in the CFA: 12-month results of the VMI-CFA study

        Koen Deloose
    12. -

      Bifurcation stenting of the common femoral artery – long term follow up of Supera cases using the Culotte technique

        Erwin Blessing
  • Thursday, January 24th: - , Room 1 - Main Arena 1

    Disruptive treatment approaches and pioneering techniques for patients with vascular disease

    Moderator:
    William Gray, Sebastian Debus
    Panel:
    Rupert Bauersachs, Marianne Brodmann, George Adams, Ramon Varcoe, Ehrin Armstrong
    1. FOCUS ON INNOVATIONS IN DRUG THERAPY

    2. -

      Understanding the latest evidence with Rivaroxaban vascular dose in PAD treatment

        Sebastian Debus
    3. -

      How can the COMPASS PAD data be applied to daily clinical practice?

        Rupert Bauersachs
    4. FOCUS ON INNOVATIONS FOR VESSEL PREPARATION

    5. -

      What lessons have we learned from DEFINITIVE AR

        Aljoscha Rastan
    6. -

      Live case transmission from Münster

        St. Franziskus Hospital Münster - Live case center
    7. FOCUS ON INNOVATIONS IN IMPLANT TECHNOLOGY

    8. -

      Future of stenting in the current DCB world

        Koen Deloose
    9. -

      Interim 2-year results from the MIMICS-2 study

        Thomas Zeller, Via satellite from Bad Krozingen
    10. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    11. -

      Live case transmission from Bad Krozingen

        Heartcenter Bad Krozingen - Live case center
    12. -

      Characterizing the relationship between oxygen measured by subcutaneous micorsensors during revascularisation procedures and wound healing in CLI patients

        Marianne Brodmann
    13. -

      Update on MIMICS-3D: Emerging real world registry data

        Michael Lichtenberg
    14. FOCUS ON INNOVATIONS FOR COMPLEX FEMORAL LESIONS - THE PERCUTANEOUS BYPASS TECHNIQUE

    15. -

      Taking the scenic route: A complex case from the DETOUR II trial

        Ehrin Armstrong
    16. -

      First time data release: Extreme SFA lesions: DETOUR I 12-month results in lesions >30cm

        Sean Lyden
    17. -

      Durability of the DETOUR procedure for percutaneous fem-pop bypass: 3-year follow-up from my first case

        Grzegorz Halena
    18. FOCUS ON STRATEGIES TO OPTIMIZE ASSESSMENT OF REVASCULARISATION RESULTS

    19. -

      Perfusion angiography: towards new standards for optimized treatment outcomes

        Daniel van den Heuvel
    20. -

      Live case transmission from Abano Terme

        Policlinico Abano Terme - Live case center
    21. FOCUS ON VENOUS DISEASE

    22. -

      Endovenous Valve Formation (EVF) – an initial report on the human clinical trial of the first non-implantable, endovenous approach to deep vein reflux

        Ramon Varcoe
    23. -

      Discussion and conclusion

  • Friday, January 25th: - , Room 1 - Main Arena 1

    Critical issues and pioneering solutions in aortic endografting - Join us for brunch, served from 08:45am until 11:00am

    Moderator:
    Martin Malina
    Panel:
    Marc van Sambeek, Thomas Larzon, Olaf Richter, Frank Veith
    live from Münster:
    Martin Austermann
    1. Treatment of ruptured aortic aneurysms – surgery vs. EVAR

        Marc van Sambeek
    2. Why the randomized trials comparing EVAR with open repair for ruptured AAAs are misleading and not generally applicable

        Frank Veith
    3. With adjuncts (Chimney grafts and Onyx) 100% of RAAAs can be treated by EVAR with low 30-day mortality and turn down rate

        Thomas Larzon
    4. R-EVAR is it feasible, how to deal with abdominal compartemental syndrome, pros and cons

        Mohamed Ismail
    5. Leaking huge AAA and bilateral iliac aneurysms. How vascular plugs help to save life during emergency EVAR

        Magdy Haggag
    6. Physician modified endograft (PMEG) for EVAR

        Taeseung Lee
    7. Urgent endovascular treatment of left uretero-iliac fistula in patient with radical cystectomy and ileal conduit urinary diversion

        Santiago Estebanez
    8. An expansion of EVAR by EVAS: a possibility in emergencies

        Maria Terzibaschian
    9. Management of infected aneurysms and grafts

        Olaf Richter
    10. A successful treatment of an infected saccular aortic aneurysm (PAU) by Chimney- EVAS: Case report

        Sotirios Goulas
    11. Tips and tricks for obtaining supraceliac aortic control with EVAR for ruptured AAAs: it is not simple

        Frank Veith
    12. Trouble shooting and bail-out in FEVAR/BEVAR

        Eric Verhoeven
    13. Nobilizing the chEVAR experience through standardization; How a standard approach improves patient outcomes

        Peter Holt
    14. Emergent use of an arch branch device to treat an ascending aortic rupture with use of a branch-to-branch through-and-through wire

        Ahmed Eleshra